TABLE 3.

Multivariable Regression Analysis for Major Adverse Kidney Events at 90 Days in Patients With Thrombocytopenia

Characteristic (n = 284)	OR (95% CI); p
Baseline serum creatinine	1.30 (0.79–2.13); 0.31
Chronic kidney disease	7.51 (0.94–59.73); 0.06
Pediatric Logistic Organ Dysfunction-2 score at CKRT initiation	1.10 (1.02–1.19); 0.02
Therapeutic plasma exchange during CKRT course	0.35 (0.20–0.60); < 0.001
Methicillin-resistant Staphylococcus aureus during ICU admission	1.87 (0.71–4.91); 0.21

CKRT = continuous kidney replacement therapy, OR = odds ratio.